TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARVN

Arvinas Inc

Healthcare · Biotechnology

8.30$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARVN
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-415.2% -148.9%
-20.4% +103.2% +219.1% +78.6% +49.1% +36.7% -18.3% -1.5% -21.2%
-53.4% +4,646.1% +72.6% +50.5% +89.1% +32.2% -5.2% +23.2% -50.1%
+959.2% +1,927.1% +69.8% +48.6% +120.2% +14.9%
-55.5% -42.9% -182.8% -112.2%
+230.1% +179.6% +120.6% +3.3% -27.1% +44.7% -57.4% -37.9% +5.6%
-960.8% -48.2% -899.8% -16.2% -82.9% +1,074.6%
-94.3%
-82.6% +4,795.9% -66.4% -100.0%
+7.8% -109.3% -50.0%
+7.8% -16.8% +261.1% -44.8% -98.3% +7,872.3% -97.9% -1,257.0%
-207.4% +9,519.0% -182.1% -194.1%
-562.1% -150.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?